Protective effects of silymarin against paclitaxel-induced cardiac toxicity
dc.authorid | AKTAS, IBRAHIM/0000-0002-0956-8204 | |
dc.authorid | Bilgic, Sedat/0000-0001-8410-2685 | |
dc.authorid | Martinez, Jose/0000-0002-0177-4847 | |
dc.authorid | GUR, FATIH MEHMET/0000-0001-7748-3272 | |
dc.contributor.author | Aktas, Ibrahim | |
dc.contributor.author | Gur, Fatih Mehmet | |
dc.contributor.author | Martinez, Jose L. | |
dc.contributor.author | Bilgic, Sedat | |
dc.contributor.author | Korkoca, Hanifi | |
dc.date.accessioned | 2024-11-07T13:34:15Z | |
dc.date.available | 2024-11-07T13:34:15Z | |
dc.date.issued | 2024 | |
dc.department | Niğde Ömer Halisdemir Üniversitesi | |
dc.description.abstract | In this study, the protectivity of silymarin (SY) against the harmful effects of paclitaxel (PX) on the heart was investigated. PX was administered 2 mg/kg intraperitoneally to the PX group, 100 mg/kg SY was administered by gavage to the SY group, and both drugs were administered to the PX + SY group as other groups. Treatment with SY significantly decreased cardiac troponin I (cTn-I), brain natriuretic peptide (BNP), creatine kinase isoenzyme MB (CK-MB) and lactate dehydrogenase (LDH) levels. In the PX group; the decrease in glutathione (GSH), catalase (CAT) and superoxide dismutase (SOD) levels and the increase in malondialdehyde (MDA) levels were significantly normalized with SY administration. Histologically; heart injury was significantly reduced in the PX + SY group compared to the PX group. As a result, it was determined that SY, which has antioxidant, anti-apoptotic and anti-inflammatory effects, could protect the heart tissue from the toxic effects of PX. | |
dc.identifier.doi | 10.37360/blacpma.24.23.5.47 | |
dc.identifier.endpage | 759 | |
dc.identifier.issn | 0717-7917 | |
dc.identifier.issue | 5 | |
dc.identifier.scopus | 2-s2.0-85195312636 | |
dc.identifier.scopusquality | Q3 | |
dc.identifier.startpage | 749 | |
dc.identifier.uri | https://doi.org/10.37360/blacpma.24.23.5.47 | |
dc.identifier.uri | https://hdl.handle.net/11480/15862 | |
dc.identifier.volume | 23 | |
dc.identifier.wos | WOS:001234153100002 | |
dc.identifier.wosquality | N/A | |
dc.indekslendigikaynak | Web of Science | |
dc.indekslendigikaynak | Scopus | |
dc.language.iso | en | |
dc.publisher | Ms-Editions | |
dc.relation.ispartof | Boletin Latinoamericano Y Del Caribe De Plantas Medicinales Y Aromaticas | |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | |
dc.rights | info:eu-repo/semantics/closedAccess | |
dc.snmz | KA_20241106 | |
dc.subject | Heart damage | |
dc.subject | Paclitaxel | |
dc.subject | Rat | |
dc.subject | Silymarin | |
dc.subject | Oxidative stress | |
dc.title | Protective effects of silymarin against paclitaxel-induced cardiac toxicity | |
dc.title.alternative | Efectos protectores de silymarin contra toxicidad cardiaca inducida por paclitaxel | |
dc.type | Article |